课题基金 / 基金详情

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
鉴定芳基烃受体作为 HIV-1 潜伏期的新型药物调节剂
批准号：
493698
负责人：
Ancuta Petronela
金额：
$7.29万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=493698&lang=en
关键词：
Antiretroviral Therapy Confocal Microscopy/Imagestream Crispr Cas9 Flow Cytometry Analysis And Sorting Hiv-1 Humanized Mice For Hiv Infection Latency Reversing Agents Pcr/Rt-Pcr Rna Sequencing Viral Reservoirs

项目摘要

项目成果

Ancuta Petronela的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The discovery of human immunodeficiency virus type 1 (HIV-1) in 1983 was followed by major advances in understanding disease pathogenesis and the elucidation of the viral replication cycle at the molecular level. This knowledge allowed the design of the a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Finding the Perfect Time to Hunt for HIV: A Tale of 36 Hours at the CHUM
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
Targeting mTOR to restore mucosal immunity toward remission in HIV-infected individuals